Beyond the Checkbook: Lendmark’s Decade of Partnership Fuels Childhood Cancer Research

ATLANTA, GA – November 3, 2025 – In an era where corporate social responsibility is often measured in one-off donations, Lendmark Financial Services is demonstrating the power of sustained commitment. The household lender recently surpassed the $10 million mark in fundraising for CURE Childhood Cancer through its decade-long ‘Climb to Cure’ campaign, raising $2.1 million in 2025 alone. This commitment isn’t just about writing a check; it’s about forging a strategic partnership that's driving real progress in a field desperately needing innovative funding models.

For CURE Childhood Cancer, a non-profit dedicated to funding targeted pediatric cancer research, the consistent support from Lendmark has been a game-changer. “We rely on consistent funding to sustain our research programs,” explained a spokesperson for CURE. “Fluctuating donations make long-term planning difficult. Lendmark’s commitment allows us to pursue ambitious projects and build momentum in our quest for a cure.”

A Shift in Philanthropic Strategy

Traditional corporate philanthropy often focuses on short-term donations or event sponsorships. While valuable, these contributions don’t always provide the stability needed for long-term research initiatives. Lendmark’s approach, however, is different. By committing to a decade-long partnership, the company has enabled CURE to invest in projects with longer timelines and greater potential impact.

“We believe in building relationships, not just writing checks,” said Bobby Aiken, Founder and CEO of Lendmark Financial Services, in a statement. “The greatest gift is the giving of life, and when we can contribute to a child’s fight against cancer, it's incredibly rewarding.”

The commitment is attracting attention from other organizations looking to maximize their philanthropic impact. Experts suggest this model, prioritizing long-term partnerships, is gaining traction as non-profits seek more predictable funding streams. A financial analyst specializing in non-profit funding stated, “Sustainability is key. Companies are realizing that consistent support is more effective than sporadic bursts of generosity.”

Targeted Research: A Promising Approach

The funding from Lendmark is directly supporting CURE's efforts in targeted cancer research – a rapidly evolving field focusing on treatments tailored to the specific genetic characteristics of each patient’s cancer. This approach differs from traditional chemotherapy and radiation, which often affect healthy cells alongside cancerous ones.

According to CURE researchers, targeted therapies have shown promising results in improving outcomes for children with certain types of cancer. “We’re seeing significant progress in identifying specific genetic mutations that drive cancer growth,” said a CURE research scientist. “This allows us to develop drugs that specifically target those mutations, minimizing side effects and maximizing effectiveness.”

The funds are also being used to support family assistance programs, providing emotional, financial, and logistical support to families navigating the challenges of childhood cancer. “The emotional and financial burden on families affected by cancer is immense,” explained a family support specialist at CURE. “Lendmark's support helps us provide critical resources, allowing families to focus on their child’s well-being.”

Local Roots, National Impact

While Lendmark Financial Services operates nationwide, the company maintains strong ties to the communities it serves. The ‘Climb to Cure’ campaign actively engages employees and customers, fostering a sense of community involvement. “Our employees are passionate about supporting this cause,” said a Lendmark representative. “It’s a way for us to give back and make a difference in the lives of children and families.”

This commitment to local engagement is bolstering Lendmark’s brand reputation and fostering customer loyalty. “Consumers are increasingly seeking out companies that align with their values,” said a marketing consultant specializing in corporate social responsibility. “Lendmark’s commitment to childhood cancer research is a powerful differentiator.”

Beyond the Decade Mark

As Lendmark celebrates a decade of partnership with CURE Childhood Cancer, the company shows no signs of slowing down. The commitment to long-term funding, combined with a focus on targeted research and community engagement, is setting a new standard for corporate social responsibility.

“We’re incredibly grateful for Lendmark’s unwavering support,” said a spokesperson for CURE. “Together, we’re making a real difference in the fight against childhood cancer.”

While a cure remains elusive, the consistent funding and strategic partnership between Lendmark and CURE provide a beacon of hope for children and families affected by this devastating disease. This isn't simply a story about philanthropy; it’s a testament to the power of long-term commitment and the potential for meaningful impact when businesses prioritize social responsibility alongside profit.

Ultimately, Lendmark’s approach is a reminder that true impact extends far beyond a one-time donation—it’s about building lasting relationships and investing in a future where every child has the opportunity to thrive.